Transine Therapeutics Ltd closes £13.7m seed financing
Transine Therapeutics Ltd has added £4.6m from lead investor Epidarex Capital and the Dementia Discovery Fund (DDF) to its £9.1m seed funding led by Takeda Ventures and DDF.
Orphan drug developer Minoryx raises 51m
Minoryx Therapeutics SL has closed a 51m financing, including Series C equity financing and complementary bank debt to commercialise X-ALD drug leriglitazone.
G7 heads call for decarbonisation of industry
G7 Climate, Energy and Environment Ministers have announced a wide range of actions to tackle the triple global crisis of climate change, biodiversity loss and pollution".
Ellipses Pharma licences SRB22 from SunRock Biopharma
Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional HER3:TRAIL fusion protein set to eliminate solid tumours.
Evotec signs contracts with Almirall and Sernova
Hamburg-based CRO Evotec SE has inked a drug development partnership with Spanish Almirall SA in dematology.
Avantium gets EU grant
Avantium NV will get a 3m EU funding for a feasibility study of the electrochemical conversion of CO2 to consumer products.
Enzymaster raises $45m in Series C round
Biocatalysis expert Enzymaster (Germany, China, Singapore) has cashed in $45m to expand its production capacity of engineered biosynthetic enzymes.
EU starts consultation on novel plant breeding methods
The EU Commission has launched its final consultation on the deregulation of new breeding techniques in agriculture.
Hot of the press: BIOTECH Insight Newsletter
Deutsche Börse report key growth figures of the German biotech sector in 2021 in BIOTECH Insight, its new online information service published in collaboration with BIOCOM AG.
Engimmune Therapeutics raises CHF15.5m in seed financing
Cancer specialist Engimmune Therapeutics has raised CHF15.5m in a seed financing to expand its pipeline of T-cell receptor therapeutics.